(BMRN) Biomarin Pharmaceutical complete technical analysis [charts+indicators] | Buy/Sell Biomarin Pharmaceutical | (BMRN) share price targets
Complete technical analysis of Biomarin Pharmaceutical (BMRN) by charts plus indicators, forecast predictions and share price targets for Biomarin Pharmaceutical (BMRN)
Biomarin Pharmaceutical trades in USA in Health Care sector.
Showing technical analysis as on 2025-11-10 View latest technical analysis
10 day averaged volume of Biomarin Pharmaceutical is 3605230
| Date | Daily Closing Price | Open | High | Low | Volume |
| 10 Mon Nov 2025 | 52.67 | 51.94 | 52.80 | 51.81 | 0.574 times |
| 07 Fri Nov 2025 | 51.46 | 51.90 | 51.90 | 50.76 | 0.859 times |
| 06 Thu Nov 2025 | 51.84 | 52.03 | 52.68 | 51.42 | 0.82 times |
| 05 Wed Nov 2025 | 52.80 | 52.17 | 53.50 | 51.86 | 0.588 times |
| 04 Tue Nov 2025 | 52.52 | 52.56 | 52.76 | 51.80 | 0.552 times |
| 31 Fri Oct 2025 | 53.57 | 51.33 | 53.62 | 51.00 | 0.902 times |
| 31 Fri Oct 2025 | 53.57 | 51.33 | 53.62 | 51.00 | 0.902 times |
| 30 Thu Oct 2025 | 51.91 | 51.86 | 52.49 | 51.10 | 0.74 times |
| 29 Wed Oct 2025 | 51.86 | 53.46 | 54.75 | 51.74 | 1.319 times |
| 28 Tue Oct 2025 | 53.49 | 53.40 | 56.80 | 53.27 | 1.79 times |
My analysis of stock is bearish for shortterm, and stock might move down till 52.2 or till 51.2. Use a stoploss of 52.97 and if the stock hits stoploss, then it can shoot up till 53.79
Share price targets for Biomarin Pharmaceutical (BMRN)
| Target Type | Value |
| Downside Target | 50.76 |
| Upside Target | 53.62 |
| Upside Target | 54.63 |
| Upside Target | 55.03 |
| Upside Target | 56.36 |
| Upside Target | 56.80 |
| Upside Target | 59.79 |
| Upside Target | 60.43 |
| Upside Target | 63.97 |
Intraday share price targets for Biomarin Pharmaceutical (BMRN)
| Target Type | Value |
| Downside Intraday Target | 52.05 |
| Downside Intraday Target | 51.44 |
| Upside Intraday Target | 53.04 |
| Upside Intraday Target | 53.42 |
| Downside Intraday Target | 52.43 |
Weekly technical analysis of Biomarin Pharmaceutical (BMRN)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 10 Mon Nov 2025 | 52.67 | 51.94 | 52.80 | 51.81 | 0.204 times |
| 07 Fri Nov 2025 | 51.46 | 52.56 | 53.50 | 50.76 | 3.127 times |
| 31 Fri Oct 2025 | 53.57 | 51.33 | 53.62 | 51.00 | 0.144 times |
| 31 Fri Oct 2025 | 53.57 | 54.98 | 56.80 | 51.00 | 2.085 times |
| 24 Fri Oct 2025 | 54.48 | 53.55 | 55.03 | 52.14 | 1.018 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Biomarin Pharmaceutical (BMRN)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 10 Mon Nov 2025 | 52.67 | 52.56 | 53.50 | 50.76 | 0.189 times |
| 31 Fri Oct 2025 | 53.57 | 54.29 | 56.80 | 51.00 | 1.494 times |
| 30 Tue Sep 2025 | 54.16 | 58.40 | 59.79 | 52.47 | 0.933 times |
| 29 Fri Aug 2025 | 58.27 | 57.50 | 63.97 | 56.36 | 1.168 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Biomarin Pharmaceutical (BMRN)
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Biomarin Pharmaceutical in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Biomarin Pharmaceutical Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Biomarin Pharmaceutical in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 52.64 and Biomarin Pharmaceutical (BMRN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Biomarin Pharmaceutical in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Biomarin Pharmaceutical Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Biomarin Pharmaceutical in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 52.64 and Biomarin Pharmaceutical (BMRN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

